Shin Min-Jeong, Chung Namsik, Lee Jong Ho, Jang Yangsoo, Park Eunju, Jeon Kyung-Im, Chung Ji Hyung, Seo Bo-Young
Yonsei Cardiovascular Research Institute, Yonsei University College of Medicine, Seoul 120-752, South Korea.
Int J Cardiol. 2007 May 31;118(2):173-7. doi: 10.1016/j.ijcard.2006.03.089. Epub 2006 Sep 26.
Statins are known to possess antioxidant properties in addition to their cholesterol-lowering effects. However, recent studies have suggested that statins reduce the levels of antioxidant vitamins such as vitamin E and coenzyme Q(10), possibly resulting in impaired left ventricular function. We investigated the effects of simvastatin on the blood lipids, LDL oxidation and plasma antioxidant status, and whether these effects were associated with changes in plasma antioxidant vitamin levels.
Simvastatin (20-40 mg/day) was administered for 8 weeks in seventy-six hypercholesterolemic patients. We measured plasma lipids, oxidized LDL, total radical trapping antioxidant potential (TRAP) and plasma antioxidant vitamin levels at baseline and after 8 weeks of simvastatin administration.
Simvastatin significantly lowered serum levels of total cholesterol and LDL-cholesterol by 30.1% and 41.9%, respectively. A significant reduction in oxidized LDL levels (p<0.0001) and improvement in plasma antioxidant status as measured by TRAP (p<0.05) after the 8-week simvastatin treatment were observed. Regarding the effects of simvastatin on plasma antioxidant vitamin levels, there were significant increases in the levels of lipid-corrected retinol (p<0.001), alpha-tocopherol (p<0.001) and gamma-tocopherol (p<0.005) after the 8-week simvastatin treatment. Lipid-corrected levels of coenzyme Q10 and carotenoids remained unchanged after simvastatin treatment.
Our results show that simvastatin reduced blood lipids and circulating oxidized LDL, and improved plasma antioxidant status without altering the antioxidant vitamin system. These data indicate that simvastatin not only decreases blood lipids and circulating oxidized LDL but also increases lipid corrected levels of antioxidant vitamins and may improve plasma antioxidant status synergizing with the biological effects of antioxidants.
他汀类药物除具有降胆固醇作用外,还具有抗氧化特性。然而,最近的研究表明,他汀类药物会降低抗氧化维生素如维生素E和辅酶Q10的水平,这可能导致左心室功能受损。我们研究了辛伐他汀对血脂、低密度脂蛋白氧化和血浆抗氧化状态的影响,以及这些影响是否与血浆抗氧化维生素水平的变化有关。
76例高胆固醇血症患者接受辛伐他汀(20 - 40毫克/天)治疗8周。我们在基线时以及辛伐他汀治疗8周后测量了血浆脂质、氧化型低密度脂蛋白、总自由基捕获抗氧化能力(TRAP)和血浆抗氧化维生素水平。
辛伐他汀使血清总胆固醇和低密度脂蛋白胆固醇水平分别显著降低了30.1%和41.9%。在8周的辛伐他汀治疗后,观察到氧化型低密度脂蛋白水平显著降低(p<0.0001),并且通过TRAP测量的血浆抗氧化状态得到改善(p<0.05)。关于辛伐他汀对血浆抗氧化维生素水平的影响,在8周的辛伐他汀治疗后,脂质校正的视黄醇水平(p<0.001)、α-生育酚水平(p<0.001)和γ-生育酚水平(p<0.005)均显著升高。辛伐他汀治疗后,脂质校正的辅酶Q10和类胡萝卜素水平保持不变。
我们的结果表明,辛伐他汀降低了血脂和循环中的氧化型低密度脂蛋白,并改善了血浆抗氧化状态,而未改变抗氧化维生素系统。这些数据表明,辛伐他汀不仅降低血脂和循环中的氧化型低密度脂蛋白,还提高了脂质校正的抗氧化维生素水平,并可能与抗氧化剂的生物学效应协同改善血浆抗氧化状态。